A traditional Chinese medicine composition for treating chronic hepatitis, splenomegaly and liver cirrhosis

Abstract

The invention relates to a Chinese medicinal composition for treating chronic hepatitis, splenauxe and cirrhosis. The Chinese medicinal composition consists of the following Chinese herbal medicines in part by weight: 20 to 30 parts of Chinese angelica, 15 to 25 parts of white paeony root, 20 to 40 parts of tortoise plastron, 18 to 30 parts of starfish, 30 to 60 parts of turtle shell, 12 to 24 parts of bupleurum, 15 to 30 parts of ginseng, 30 to 60 parts of astragalus, 15 to 30 parts of garden burnet root, 6 to 15 parts of zedoary, 6 to 20 parts of rhubarb and 12 to 25 parts of root of red-rooted salvia. The Chinese medicinal composition can be prepared into water pills to be taken directly, and is obvious in a curative effect and convenient to take. By clinical observation, the effectiverate is 93 percent, and the diseases do not relapse after healing.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating chronic hepatitis, splenomegaly and liver cirrhosis. Background technique [0002] "Chronic hepatitis → liver fibrosis → liver cirrhosis → liver cancer" is a path of liver disease evolution, which poses a considerable threat to the survival of patients. Liver cirrhosis is a common chronic liver disease, which can be caused by one or more reasons, and the liver is progressive, diffuse, and fibrous. The specific manifestation is diffuse degeneration and necrosis of liver cells, followed by fibrous tissue hyperplasia and nodular regeneration of liver cells. These three changes are repeated and interlaced, resulting in the gradual remodeling of the structure of liver lobules and blood circulation pathways, causing the liver to deform, harden and rot. lead to cirrhosis of the liver. Splenomegaly is often t...

AI Technical Summary

Problems solved by technology

[0005]The conventional Chinese medicine currently used to treat liver cirrhosis and splenomegaly has defects such as ineffectiveness and slow effect, so that many patients suffer from liver fibrosis. In the end, he died due to complications such as gastrointestinal bleeding and hepatic encephalopathy, which brought great pain to the patient and his family.